Amendments to the 2009 Eagle/Xxxxxx Agreement. On December 23, 2010, the XXXXXX and EAGLE amended the February 13, 2009 License and Development Agreement (the “2009 Eagle/Xxxxxx Agreement”) to include [*] and [*] as PRODUCTS. The parties hereto [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. agree that such amendment, in respect of such products only, is hereby terminated and of no force and effect and that EAGLE shall have no rights, and XXXXXX shall have no obligations, in respect of such products under the 2009 Eagle/Xxxxxx Agreement or otherwise. For the avoidance of doubt, except as set forth in this Section 2, the 2009 Eagle/Xxxxxx Agreement, all other documents, instruments and agreements executed and/or delivered in connection therewith, shall remain in full force and effect.
Appears in 8 contracts
Samples: Development and License Agreement (Eagle Pharmaceuticals, Inc.), Original Agreement (Eagle Pharmaceuticals, Inc.), Development and License Agreement (Eagle Pharmaceuticals, Inc.)
